title: Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
authors.forename: Carlo
authors.initials: C
authors.lastname: Salvarani
authors.forename: Nicolò
authors.initials: N
authors.lastname: Pipitone
authors.forename: Luigi
authors.initials: L
authors.lastname: Boiardi
authors.forename: Gene G
authors.initials: GG
authors.lastname: Hunder
mesh_terms: D004359:Drug Therapy, Combination; D000068800:Etanercept; D013700:Giant Cell Arteritis / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011111:Polymyalgia Rheumatica / Q000150:complications / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone; D000068800:Etanercept